Author: Alexander Lee
Alexander is the founder and author of Microcaps.ca, a leading resource for investors interested in the micro-cap stock market. With a passion for uncovering hidden gems in the world of small-cap stocks, Alexander combines in-depth research with years of experience in the financial markets to provide readers with valuable insights and timely analysis. Investors should conduct their own research or consult with a qualified investment advisor before making any investment decisions. The author of this article is not responsible for any gains or losses incurred from investing in companies mentioned.
Cardiol Therapeutics is a clinical-stage life sciences company focused on the research and clinical development of anti-inflammatory and anti-fibrotic therapies for the treatment of heart disease. The company’s lead small molecule drug candidate, CardiolRx™ (cannabidiol) oral solution, is pharmaceutically manufactured and in clinical development for use in the treatment of heart disease. Cannabidiol inhibits activation of the inflammasome pathway, which plays a crucial role in the development and progression of inflammation and fibrosis associated with myocarditis, pericarditis, and heart failure. Cardiol has received authorization from the United States Food and Drug Administration to conduct clinical studies on CardiolRx for recurrent…
On September 27, 2024, Carlyle Commodities Corp. (CSE: CCC) (FSE: BJ4) (OTC Pink: CCCFF) and Miramis Mining Corp. announced their entry into an amalgamation agreement. This agreement, dated September 27, 2024, entails a wholly-owned subsidiary of Carlyle amalgamating with Miramis. Following the amalgamation, all issued and outstanding common shares of Miramis will be immediately exchanged for common shares of Carlyle on a one-to-one basis. After the completion of the Transaction, the Board of Directors and management of Carlyle will remain unchanged, and it is anticipated that shareholders of Miramis will hold approximately 28.8% of the issued and outstanding Carlyle Shares.…
/NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES/ All amounts are in Canadian dollars unless stated otherwise VANCOUVER, BC, Sept. 17, 2024 – Foran Mining Corporation (TSX: FOM) (OTCQX: FMCXF) (“Foran” or the “Company”) is pleased to announce the completion of the second tranche of its previously announced $360 million private placement financings (the “Offering”). The second tranche, which generated aggregate gross proceeds of $70,950,788, was completed following the receipt of all requisite shareholder approvals at the special meeting of shareholders held on Monday, September 16, 2024. With the closing of the Second Tranche Offering,…
On September 26, 2024, Appia Rare Earths & Uranium Corp. (CSE: API) (OTCQX: APAAF) (FWB: A0I0) (MUN: A0I0) (BER: A0I0) announced the successful confirmation of intersecting uranium (U) and rare earth elements (REE) mineralization during exploratory drilling at the Loranger property in Saskatchewan, Canada. The results were analyzed by the Saskatchewan Research Council (SRC) Laboratories in Saskatoon, validating the Company’s early-stage geological hypotheses. The drill program identified variable-length electromagnetic conductors conducive to U and REE mineralization, indicating the Loranger property’s potential as a dual-commodity site within Appia’s portfolio. Highlights of the assay results included significant U and REE mineralization in…
On September 27, 2024, Greenfire Resources Ltd., an energy company based in Calgary, Alberta, provided an update regarding an application submitted to the Alberta Securities Commission. The application, made by certain limited partnerships managed by Waterous Energy Fund Management Corp. together with other entities, requested that the ASC cease trade the Company’s shareholder protection rights plan agreement. The Rights Plan was put in place in response to a recent announcement involving the acquisition of a significant portion of Greenfire’s common shares by WEF and other entities. Greenfire intends to defend the necessity of the Rights Plan at the ASC hearing,…
On September 26, 2024, Cansortium Inc., a vertically-integrated cannabis company operating under the Fluent™ brand, announced a change in auditors from Baker Tilly US, LLP to PKF O’Connor Davies LLP. The Former Auditor resigned at the request of the company, with the Successor Auditor appointed effective September 23, 2024, until the next annual meeting. No modified opinions were expressed in the Former Auditor’s reports during the relevant period, and there were no reportable events involving the Company and the Former Auditor. The notice of change of auditor has been filed on SEDAR in accordance with National Instrument 51-102. Cansortium Inc.…
Vancouver, British Columbia–(September 9, 2024) – An announcement was made by LaFleur Minerals Inc. (“LaFleur” or the “Company”) regarding the revision of the terms of its non-brokered private placement, as initially disclosed on June 21, 2024. The Company is now set to conduct a non-brokered private placement offering of up to 10,000,000 units (the “Units”) at a price of $0.30 per Unit, aiming for gross proceeds of up to $3,000,000 (the “Offering”). Each Unit will comprise one common share in the capital of the Company (a “Common Share”) and one Common Share purchase warrant (a “Warrant”). Each Warrant holder will…
Canada’s main stock index remained relatively unchanged on Friday after reaching a record high in the previous session. The energy sector experienced gains on the TSX, while the tech sector saw a decline. The July GDP grew by 0.2 per cent, driven by increases in both services-producing and goods-producing industries. The Dow Jones Industrial Average reached a new record level as investors analyzed new data showing progress in reducing inflation. The personal consumption expenditures price index for August, which is the Federal Reserve’s preferred inflation measure, rose by 0.1 per cent, in line with economists’ expectations. On an annual basis,…
The following is a transcription of a recent interview with Sara Akbar, Director and Chairperson of the Board of a petroleum company. Akbar shared her background, experience, and vision for the company. She began her career as a petroleum engineer, becoming the first female field engineer in Kuwait in 1981. She later worked onshore and offshore, including firefighting during the 1990 invasion when 735 oil wells were on fire. Akbar then discussed her role in creating the first upstream oil and gas private company in the region, which was successful and eventually sold to a Chinese company in 2017. Currently,…
Avicanna Inc. has recently introduced a significant real-world evidence study on medical cannabis through the MyMedi.ca medical cannabis care platform. This study will be overseen by Hance Clarke, MD, FRCPC, Ph.D., who currently serves as the president of The Canadian Pain Society and the Canadian Consortium for the Investigation of Cannabinoids. For more detailed information on this announcement, please refer to the full article provided in this link. In addition to this, here are some top cannabis news stories from the past week: 1. Tilray has revealed a new lineup of hemp-derived delta-9 THC drinks. 2. GCAC and Grunt Style…